« Decline In Teenage Birth Rates, Tobacco Use Offer Blacks Hope For Future
WFP Aims To Help Malawi People Affected By HIV/AIDS »

Roche’s Organ-Rejection Drug CellCept Increases Risk Of Birth Defects

Roche’s organ-rejection drug CellCept increases the risk of birth defects and miscarriage during the first trimester of pregnancy.

This entry was posted on Wednesday, October 31st, 2007 at 1:10 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.